Zobrazeno 1 - 10
of 191
pro vyhledávání: '"Dana Horakova"'
Autor:
Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Cathérine Dekeyser, Guy Laureys, Bart Van Wijmeersch, Veronica Popescu, Tom Dhaene, Dirk Deschrijver, Willem Waegeman, Bernard De Baets, Michiel Stock, Dana Horakova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Pierre Grammond, Tomas Kalincik, Raed Alroughani, Francois Grand'Maison, Olga Skibina, Murat Terzi, Jeannette Lechner-Scott, Oliver Gerlach, Samia J Khoury, Elisabetta Cartechini, Vincent Van Pesch, Maria José Sà, Bianca Weinstock-Guttman, Yolanda Blanco, Radek Ampapa, Daniele Spitaleri, Claudio Solaro, Davide Maimone, Aysun Soysal, Gerardo Iuliano, Riadh Gouider, Tamara Castillo-Triviño, José Luis Sánchez-Menoyo, Anneke van der Walt, Jiwon Oh, Eduardo Aguera-Morales, Ayse Altintas, Abdullah Al-Asmi, Koen de Gans, Yara Fragoso, Tunde Csepany, Suzanne Hodgkinson, Norma Deri, Talal Al-Harbi, Bruce Taylor, Orla Gray, Patrice Lalive, Csilla Rozsa, Chris McGuigan, Allan Kermode, Angel Pérez Sempere, Simu Mihaela, Magdolna Simo, Todd Hardy, Danny Decoo, Stella Hughes, Nikolaos Grigoriadis, Attila Sas, Norbert Vella, Yves Moreau, Liesbet Peeters
Publikováno v:
PLOS Digital Health, Vol 3, Iss 7, p e0000533 (2024)
BackgroundDisability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability progression have not yet reached the level of trust needed to be adopted in the
Externí odkaz:
https://doaj.org/article/c8086e53dc844308be0ea446e3a32319
Autor:
Pavel Potuznik, Jiri Drahota, Dana Horakova, Marek Peterka, Aneta Mazouchova, David Matyas, Zbysek Pavelek, Marta Vachova, Eva Recmanova, Ivana Stetkarova, Jana Libertinova, Jan Mares, Pavel Stourac, Marketa Grunermelova, Alena Martinkova, Jana Adamkova, Pavel Hradilek, Radek Ampapa, Michal Dufek, Eva Kubala Havrdova, Dominika Stastna
Publikováno v:
Journal of Central Nervous System Disease, Vol 16 (2024)
Background Cladribine, a selective immune reconstitution therapy, is approved for the treatment of adult patients with highly active multiple sclerosis (MS). Objectives Provide experience with cladribine therapy in a real-world setting. Methods This
Externí odkaz:
https://doaj.org/article/184f4c6999bb4bada8b072f3e0cb99d2
Autor:
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Aggressive disease control soon after multiple sclerosis (MS) diagnosis may prevent irreversible neurological damage, and therefore early initiation of a high-efficacy disease-modifying therapy (DMT) is of clinical relevance. Objectives:
Externí odkaz:
https://doaj.org/article/5f44ff79362846b78e7b847750fa6b7f
Autor:
Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Jan Hillert, Lars Forsberg, Anna Glaser, Ali Manouchehrinia, Ryan Ramanujam, Tim Spelman, Pernilla Klyve, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Helmut Butzkueven, Anneke Van Der Walt, Vladimir Bezlyak, Carol Lines, Rod Middleton
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Introduction: Prescribing guidance for disease-modifying treatment (DMT) in multiple sclerosis (MS) is centred on a clinical diagnosis of relapsing–remitting MS (RRMS). DMT prescription guidelines and monitoring vary across countries. Standardising
Externí odkaz:
https://doaj.org/article/94019eea78bf46cdb31bf422481b6086
Autor:
Petra Nytrova, Dominika Stastna, Adam Tesar, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundRituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these therapies influence T-cell-mediated immune response against SARS-CoV-2 after immunizat
Externí odkaz:
https://doaj.org/article/fd83e3caa4d14846b4d386ffddd286ce
Autor:
Michaela Andelova, Karolina Vodehnalova, Jan Krasensky, Eliska Hardubejova, Tereza Hrnciarova, Barbora Srpova, Tomas Uher, Ingrid Menkyova, Dominika Stastna, Lucie Friedova, Jiri Motyl, Jana Lizrova Preiningerova, Eva Kubala Havrdova, Bénédicte Maréchal, Mário João Fartaria, Tobias Kober, Dana Horakova, Manuela Vaneckova
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Early infratentorial and focal spinal cord lesions on magnetic resonance imaging (MRI) are associated with a higher risk of long-term disability in patients with multiple sclerosis (MS). The role of diffuse spinal cord lesions rem
Externí odkaz:
https://doaj.org/article/4e0b4523cfb94fc49b3da5a0513014e1
Autor:
Andrea Burgetova, Petr Dusek, Tomas Uher, Manuela Vaneckova, Martin Vejrazka, Romana Burgetova, Dana Horakova, Barbora Srpova, Marta Kalousova, Libuse Noskova, Katerina Levova, Jan Krasensky, Lukas Lambert
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10048 (2023)
In this prospective longitudinal study, we quantified regional brain volume and susceptibility changes during the first two years after the diagnosis of multiple sclerosis (MS) and identified their association with cerebrospinal fluid (CSF) markers a
Externí odkaz:
https://doaj.org/article/54c2d646b62546f3965212b7e3811ab3
Autor:
Simona Rolla, Stefania Federica De Mercanti, Valentina Bardina, Alessandro Maglione, Daniela Taverna, Francesco Novelli, Eleonora Cocco, Anton Vladic, Mario Habek, Ivan Adamec, Pietro Osvaldo Luigi Annovazzi, Dana Horakova, Marinella Clerico
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionAlemtuzumab is highly effective in the treatment of patients with relapsing multiple sclerosis (PwRMS) and selectively targets the CD52 antigen, with a consequent profound lymphopenia, particularly of CD4+ T lymphocytes. However, the immu
Externí odkaz:
https://doaj.org/article/507cd0b961be4653b64cbc7164879e06
Autor:
Manuela Vaneckova, Gian Franco Piredda, Michaela Andelova, Jan Krasensky, Tomas Uher, Barbora Srpova, Eva Kubala Havrdova, Karolina Vodehnalova, Dana Horakova, Tom Hilbert, Bénédicte Maréchal, Mário João Fartaria, Veronica Ravano, Tobias Kober
Publikováno v:
NeuroImage: Clinical, Vol 34, Iss , Pp 103009- (2022)
Objective: Pathology in multiple sclerosis is not homogenously distributed. Recently, it has been shown that structures adjacent to CSF are more severely affected. A gradient of brain tissue involvement was shown with more severe pathology in periven
Externí odkaz:
https://doaj.org/article/1506ff374cea4f969247281418142c5b
Autor:
Marco Onofrj, Dana Horakova, Pierre Duquette, Pierre Grammond, Serkan Ozakbas, Murat Terzi, Jeannette Lechner-Scott, Cavit Boz, Patrizia Sola, Franco Granella, Roberto Bergamaschi, Recai Turkoglu, Vincent Van Pesch, Raed Alroughani, Bassem Yamout, Radek Ampapa, Suzanne Hodgkinson, Helmut Butzkueven, Jim Stankovich, Albert Saiz, Michael Barnett, Richard Macdonell, Maria Pia Amato, Anneke Van Der Walt, Francesco Patti, Ayse Altintas, Pamela McCombe, Wei Z Yeh, Olga Skibina, Celia Oreja-Guevara, Tamara Castillo-Trivino, Putu A Widyastuti, Eva K Havrdova, Karolina Vodehnalova, Sara Eichau, Maria J Sá, Francois Grand’Maison, Daniele LA Spitaleri, Elisabetta Cartechini, Aysun Soysal, Melissa Gresle, Tomas Uher, Davide Maimone, Raymond MM Hupperts, Vilija G Jokubaitis, MSBase Registry
Publikováno v:
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Externí odkaz:
https://doaj.org/article/73f419e780b84c59bc44cdd952fe9689